1-12 of 12
Yucai Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium

Jonathan R Day, Melissa C. Larson, Urshila Durani, Jean L Koff, Yucai Wang, Thomas M. Habermann, Izidore S Lossos, Loretta J. Nastoupil, Christopher S Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B Cohen, Brad S. Kahl, Jia Ruan, Richard Burack, Jonathan W. Friedberg, James R Cerhan, Christopher R. Flowers, Brian L Link, Matthew J. Maurer, Carla Casulo
Journal: Blood Advances
Blood Adv bloodadvances.2024014053.
https://doi.org/10.1182/bloodadvances.2024014053
Published: 2024
Includes: Supplemental data
Journal Articles

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature

Clinical Trials & Observations
Côme Bommier, Brian K. Link, Brianna J. Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie A. Thompson, Dai Chihara, Juan P. Alderuccio, Jean L. Koff, Narendranath Epperla, Annarita Conconi, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood Advances
Blood Adv (2024) 8 (23): 5939–5948.
https://doi.org/10.1182/bloodadvances.2024013188
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy

Omran Saifi, William G. Breen, Scott C. Lester, William G. Rule, Bradley J. Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A. Hathcock, Patrick B. Johnston, Stephen M. Ansell, Jonas Paludo, Arushi Khurana, Jose C. Villasboas, Yucai Wang, Madiha Iqbal, Muhamad Alhaj Moustafa, Hemant S. Murthy, Ernesto Ayala, Mohamed A. Kharfan-Dabaja, Bradford S. Hoppe, Jennifer L. Peterson
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4877–4885.
https://doi.org/10.1182/bloodadvances.2024013647
Published: 2024
Journal Articles

Defining primary refractory large B-cell lymphoma

Allison M. Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew J. Maurer, Amy Ayers, Brad S. Kahl, Peter Martin, Jonathon B. Cohen, Carla Casulo, Izidore S. Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M. Habermann, Thomas E. Witzig, Christopher R. Flowers, James R. Cerhan, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3402–3415.
https://doi.org/10.1182/bloodadvances.2024012760
Published: 2024
Includes: Supplemental data
Journal Articles

A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia

Clinical Trials & Observations
Paul J. Hampel, Mahesh Swaminathan, Kerry A. Rogers, Erin M. Parry, Jan A. Burger, Matthew S. Davids, Wei Ding, Alessandra Ferrajoli, Jonathan M. Hyak, Nitin Jain, Saad S. Kenderian, Yucai Wang, William G. Wierda, Jennifer A. Woyach, Sameer A. Parikh, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2342–2350.
https://doi.org/10.1182/bloodadvances.2023012080
Published: 2024
Includes: Supplemental data
Journal Articles

Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Munoz, Razan Mohty, Veit L. Bücklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1857–1868.
https://doi.org/10.1182/bloodadvances.2023011767
Published: 2024
Includes: Supplemental data
Journal Articles

Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy

Clinical Trials & Observations
Evandro D. Bezerra, Madiha Iqbal, Javier Munoz, Arushi Khurana, Yucai Wang, Matthew J. Maurer, Radhika Bansal, Matthew A. Hathcock, Nora Bennani, Hemant S. Murthy, Allison C. Rosenthal, Jonas Paludo, Jose C. Villasboas, Patrick B. Johnston, Thomas M. Habermann, Stephen M. Ansell, Januario E. Castro, Thomas E. Witzig, Mohamed A. Kharfan-Dabaja, Grzegorz S. Nowakowski, Yi Lin
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1572–1576.
https://doi.org/10.1182/bloodadvances.2022007868
Published: 2023
Includes: Supplemental data
Journal Articles

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

Clinical Trials & Observations
Sanjal H. Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L. King, Matthew J. Maurer, James R. Cerhan, Andrew L. Feldman, Umar Farooq, Eric Mou, Thomas M. Habermann, Carrie A. Thompson, Yucai Wang, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6180–6186.
https://doi.org/10.1182/bloodadvances.2022007569
Published: 2022
Includes: Supplemental data
Journal Articles

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

Gilles Salles, Stephen J. Schuster, Martin Dreyling, Luca Fischer, John Kuruvilla, Piers E. M. Patten, Bastian von Tresckow, Sonali M. Smith, Ana Jiménez-Ubieto, Keith L. Davis, Carla Anjos, Jufen Chu, Jie Zhang, Chiara Lobetti Bodoni, Catherine Thieblemont, Nathan H. Fowler, Michael Dickinson, Joaquin Martínez-López, Yucai Wang, Brian K. Link
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5835–5843.
https://doi.org/10.1182/bloodadvances.2022008150
Published: 2022
Journal Articles

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Aung M. Tun, Arushi Khurana, Raphael Mwangi, Brian K. Link, Yucai Wang, Andrew L. Feldman, Carrie A. Thompson, Anne J. Novak, Jose C. Villasboas, Gita Thanarajasingam, Umar Farooq, Sergei Syrbu, Grzegorz S. Nowakowski, Thomas E. Witzig, Stephen M. Ansell, Lisa M. Rimsza, James R. Cerhan, Thomas M. Habermann, Matthew J. Maurer
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5210–5221.
https://doi.org/10.1182/bloodadvances.2022007990
Published: 2022
Includes: Supplemental data
Journal Articles

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes

Clinical Trials & Observations
Alessia Castellino, Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Andrew L. Feldman, Sergei I. Syrbu, Thomas M. Habermann, Jonas Paludo, David J. Inwards, Thomas E. Witzig, Stephen M. Ansell, Cristine Allmer, Susan L. Slager, Jonathon B. Cohen, Peter Martin, James R. Cerhan, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1350–1360.
https://doi.org/10.1182/bloodadvances.2021005715
Published: 2022
Includes: Supplemental data
Journal Articles

Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis

Holly A. Hill, Xinyue Qi, Preetesh Jain, Krystle Nomie, Yucai Wang, Shouhao Zhou, Michael L. Wang
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2927–2938.
https://doi.org/10.1182/bloodadvances.2019001350
Published: 2020
Includes: Supplemental data